GS
NBSE

George Soros’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

George Soros’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30
Closed -$30K – 301
2015
Q2 		$30K Buy
+30
New +$32.3K ﹤0.01% 243

Other funds holding NBSE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $152M AUM 20.58% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

George Soros's NBSE Position: Q3 2015 in Review

George Soros sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2015, closing a stake of 30 shares — an estimated $30K sold.

George Soros first reported a position in NBSE in Q2 2015 and held it in 1 quarter. The position peaked at $30K in Q2 2015. 47 funds tracked by Wall St. Rank hold NBSE as of Q3 2015.

  • George Soros reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • George Soros sold 30 NeuBase Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $30K.
  • George Soros first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • George Soros's NeuBase Therapeutics, Inc. Common Stock position peaked at $30K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Soros Fund Management's 13F filing for Q3 2015, filed 16 Nov 2015.